MP welcomes fair change to allow access to cannabis-based products for medicinal use

Stafford MP, Jeremy Lefroy has welcomed the recent announcement by the Home Secretary that, for the first time, specialist doctors now have the option to legally issue prescriptions for cannabis-based medicinal products.

The law change, laid in Parliament last week comes following a two-part review looking at the scheduling of cannabis-related medicinal products under the Misuse of Drugs Regulations 2001. The intention is to permit the access of cannabis-based products for medicinal use without the need for a Home Office license where there is a clinical need and where they present the most appropriate treatment option.

In allowing the use of cannabis-based products for medicinal purposes the government has made clear that is no intention of legalising the recreational use of cannabis.

The Advisory Council on the Misuse of Drugs (ACMD) will be conducting a long-term review of cannabis and synthetic cannabinoids. The Government will monitor the impact of the policy closely and review this when the ACMD provides its final advice.

Commenting on this change, Jeremy said: “There is strong scientific evidence that cannabis is a drug which can harm people's mental and physical health, and damage communities. However I also appreciate that there are people with chronic pain and debilitating illnesses who seek to alleviate their symptoms by using cannabis. Recent cases have shown the need to look more closely at the use of cannabis-based medicine in the healthcare sector in the UK, which is why the Government decided it was appropriate to review the scheduling of cannabis.

“This change to the regulations is about helping patients, in exceptional circumstances, get access to treatment which could work. I believe they are balanced, evidence-based and fair.”